Baker Bros. Advisors’s Lipocine LPCN Stock Holding History

Baker Bros. Advisors’s Portfolio LPCN Stock Details LPCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-28,775	Closed	-$3.38M	–	127
2015 Q1	$3.38M	Sell	28,775 -637	-2%	-$69.3K	0.03%	87
2014 Q4	$2.63M	Hold	29,412	–	–	0.03%	94
2014 Q3	$3.06M	Hold	29,412	–	–	0.04%	78
2014 Q2	$3.05M	Buy	+29,412	New	+$3.52M	0.04%	84

Other funds holding LPCN

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Baker Bros. Advisors's LPCN Position: Q2 2015 in Review

Baker Bros. Advisors sold out of Lipocine (LPCN) in Q2 2015, closing a stake of 28,775 shares — an estimated $3.38M sold.

Baker Bros. Advisors first reported a position in LPCN in Q2 2014 and held it in 4 quarters. The position peaked at $3.38M in Q1 2015. 38 funds tracked by Wall St. Rank hold LPCN as of Q2 2015.

Baker Bros. Advisors reported no remaining Lipocine position as of Q2 2015 after selling out during the quarter.
Baker Bros. Advisors sold 28,775 Lipocine shares in Q2 2015, an estimated $3.38M.
Baker Bros. Advisors first reported a position in Lipocine in Q2 2014 and held it in 4 quarters.
Baker Bros. Advisors's Lipocine position peaked at $3.38M in Q1 2015.
38 funds tracked by Wall St. Rank held Lipocine as of Q2 2015.

Based on Baker Bros. Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.